Characterization of protamine as a transfection accelerator for gene delivery

Yuri Tsuchiya, Tsuyoshi Ishii, Yoshio Okahata, Toshinori Sato

Research output: Contribution to journalArticle

24 Citations (Scopus)

Abstract

Protamine is an FDA-approved compound with a documented safety profile that facilitates efficient plasmid condensation for gene delivery by various types of cationic liposomes. It also improves adenoviral vector-mediated gene transfer as a transfection accelerator. However, there is no consensus as to the mechanism of protamine on gene delivery into cells. To analyze the uptake and subcellular distribution, plasmid and protamine were labeled with FITC and Texas-Red, respectively. Although the uptake of FITC-labeled plasmid/protamine complexes into the cells was the same as that of free FITC-labeled plasmid in HeLa, SOJ and A549 cells, they improved the transfection efficiency by several orders of magnitude. Moreover, we found that protamine derived from different sources (salmon, herring and trout sperm) had different transfection efficiencies; however, the gene transfer efficiency with protamine was lower than with optimized poly(L-lysine) and DEAE-Dextran. There were likely two main reasons: firstly, the uptake of plasmid mediated by protamine was complete within the first 10 min because the particle size increased as time passed, and secondly, the plasmid/protamine complexes were not released from endosomal membrane. These results indicate that as a transfection accelerator from an appropriate protamine source, with controlled particle size and facile release from endosomes would lead to successful gene delivery with protamine.

Original languageEnglish
Pages (from-to)519-537
Number of pages19
JournalJournal of Bioactive and Compatible Polymers
Volume21
Issue number6
DOIs
Publication statusPublished - 2006 Nov

Fingerprint

Protamines
Particle accelerators
Gene transfer
Transfection
Genes
Particle size
Plasmids
Dextran
Liposomes
Fluorescein-5-isothiocyanate
Condensation
Membranes
Particle Size
DEAE-Dextran
Trout
Salmon
Endosomes
HeLa Cells
Lysine
Spermatozoa

Keywords

  • DNA complex
  • Plasmid
  • Protamine
  • Subcellular distribution
  • Transfection

ASJC Scopus subject areas

  • Biotechnology
  • Biomaterials
  • Polymers and Plastics
  • Materials Chemistry

Cite this

Characterization of protamine as a transfection accelerator for gene delivery. / Tsuchiya, Yuri; Ishii, Tsuyoshi; Okahata, Yoshio; Sato, Toshinori.

In: Journal of Bioactive and Compatible Polymers, Vol. 21, No. 6, 11.2006, p. 519-537.

Research output: Contribution to journalArticle

Tsuchiya, Yuri ; Ishii, Tsuyoshi ; Okahata, Yoshio ; Sato, Toshinori. / Characterization of protamine as a transfection accelerator for gene delivery. In: Journal of Bioactive and Compatible Polymers. 2006 ; Vol. 21, No. 6. pp. 519-537.
@article{107bce6fa94e4710b3ba451577a7a476,
title = "Characterization of protamine as a transfection accelerator for gene delivery",
abstract = "Protamine is an FDA-approved compound with a documented safety profile that facilitates efficient plasmid condensation for gene delivery by various types of cationic liposomes. It also improves adenoviral vector-mediated gene transfer as a transfection accelerator. However, there is no consensus as to the mechanism of protamine on gene delivery into cells. To analyze the uptake and subcellular distribution, plasmid and protamine were labeled with FITC and Texas-Red, respectively. Although the uptake of FITC-labeled plasmid/protamine complexes into the cells was the same as that of free FITC-labeled plasmid in HeLa, SOJ and A549 cells, they improved the transfection efficiency by several orders of magnitude. Moreover, we found that protamine derived from different sources (salmon, herring and trout sperm) had different transfection efficiencies; however, the gene transfer efficiency with protamine was lower than with optimized poly(L-lysine) and DEAE-Dextran. There were likely two main reasons: firstly, the uptake of plasmid mediated by protamine was complete within the first 10 min because the particle size increased as time passed, and secondly, the plasmid/protamine complexes were not released from endosomal membrane. These results indicate that as a transfection accelerator from an appropriate protamine source, with controlled particle size and facile release from endosomes would lead to successful gene delivery with protamine.",
keywords = "DNA complex, Plasmid, Protamine, Subcellular distribution, Transfection",
author = "Yuri Tsuchiya and Tsuyoshi Ishii and Yoshio Okahata and Toshinori Sato",
year = "2006",
month = "11",
doi = "10.1177/0883911506070816",
language = "English",
volume = "21",
pages = "519--537",
journal = "Journal of Bioactive and Compatible Polymers",
issn = "0883-9115",
publisher = "SAGE Publications Ltd",
number = "6",

}

TY - JOUR

T1 - Characterization of protamine as a transfection accelerator for gene delivery

AU - Tsuchiya, Yuri

AU - Ishii, Tsuyoshi

AU - Okahata, Yoshio

AU - Sato, Toshinori

PY - 2006/11

Y1 - 2006/11

N2 - Protamine is an FDA-approved compound with a documented safety profile that facilitates efficient plasmid condensation for gene delivery by various types of cationic liposomes. It also improves adenoviral vector-mediated gene transfer as a transfection accelerator. However, there is no consensus as to the mechanism of protamine on gene delivery into cells. To analyze the uptake and subcellular distribution, plasmid and protamine were labeled with FITC and Texas-Red, respectively. Although the uptake of FITC-labeled plasmid/protamine complexes into the cells was the same as that of free FITC-labeled plasmid in HeLa, SOJ and A549 cells, they improved the transfection efficiency by several orders of magnitude. Moreover, we found that protamine derived from different sources (salmon, herring and trout sperm) had different transfection efficiencies; however, the gene transfer efficiency with protamine was lower than with optimized poly(L-lysine) and DEAE-Dextran. There were likely two main reasons: firstly, the uptake of plasmid mediated by protamine was complete within the first 10 min because the particle size increased as time passed, and secondly, the plasmid/protamine complexes were not released from endosomal membrane. These results indicate that as a transfection accelerator from an appropriate protamine source, with controlled particle size and facile release from endosomes would lead to successful gene delivery with protamine.

AB - Protamine is an FDA-approved compound with a documented safety profile that facilitates efficient plasmid condensation for gene delivery by various types of cationic liposomes. It also improves adenoviral vector-mediated gene transfer as a transfection accelerator. However, there is no consensus as to the mechanism of protamine on gene delivery into cells. To analyze the uptake and subcellular distribution, plasmid and protamine were labeled with FITC and Texas-Red, respectively. Although the uptake of FITC-labeled plasmid/protamine complexes into the cells was the same as that of free FITC-labeled plasmid in HeLa, SOJ and A549 cells, they improved the transfection efficiency by several orders of magnitude. Moreover, we found that protamine derived from different sources (salmon, herring and trout sperm) had different transfection efficiencies; however, the gene transfer efficiency with protamine was lower than with optimized poly(L-lysine) and DEAE-Dextran. There were likely two main reasons: firstly, the uptake of plasmid mediated by protamine was complete within the first 10 min because the particle size increased as time passed, and secondly, the plasmid/protamine complexes were not released from endosomal membrane. These results indicate that as a transfection accelerator from an appropriate protamine source, with controlled particle size and facile release from endosomes would lead to successful gene delivery with protamine.

KW - DNA complex

KW - Plasmid

KW - Protamine

KW - Subcellular distribution

KW - Transfection

UR - http://www.scopus.com/inward/record.url?scp=33750267960&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33750267960&partnerID=8YFLogxK

U2 - 10.1177/0883911506070816

DO - 10.1177/0883911506070816

M3 - Article

AN - SCOPUS:33750267960

VL - 21

SP - 519

EP - 537

JO - Journal of Bioactive and Compatible Polymers

JF - Journal of Bioactive and Compatible Polymers

SN - 0883-9115

IS - 6

ER -